


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.40%
-2.79%
+0.63%
-1.57%
HCA
HCA Healthcare
$496.85
Strengths

Earnings are forecast to grow

Expands stock buyback program

Outperform the market
Risk Analysis

Downgraded on weak valued
HCA Price Performance
$477.57 (+4.04%)
$473.2 (+5.00%)
$413.53 (+20.15%)
$320.56 (+54.99%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Eps growth

Reported a weak earnings
Rating
Rating

Downgraded on weak valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
HCA Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
HCA Street Sentiment is extremely bullish and have positive views on the near-term outlook
HCA has Low risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Dec 19, 2025
Reiterate
Outperform
Mizuho
Oct 18, 2025
Reiterate
Outperform
Mizuho
Oct 15, 2025
Reiterate
Buy
UBS
Oct 03, 2025
Reiterate
Buy
Cantor Fitzgerald
HCA
HCA Healthcare
496.85
+1.76%
GFI
Gold Fields Limited
49.95
-0.34%
REI
Ring Energy
1.14
-4.20%
NEM
Newmont
112.85
+0.54%
EMR
Emerson Electric Company
148.63
+1.14%
What is HCA current stock price?
What are HCA stock strengths?
What is HCA Risk Level?
What is HCA market cap and volume?
What is HCA current Stock IQ?
Should I buy HCA stock right now?
Is HCA a Strong Buy right now?
What does a 'Strong Buy' rating mean for HCA?
What does a 'Strong Sell' rating mean for HCA?
What factors influence HCA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.40%
-2.79%
+0.63%
-1.57%
HCA
HCA Healthcare
Current Price
$496.85
Recently Viewed
HCA
HCA Healthcare
496.85
+1.76%
GFI
Gold Fields Limited
49.95
-0.34%
REI
Ring Energy
1.14
-4.20%
NEM
Newmont
112.85
+0.54%
EMR
Emerson Electric Company
148.63
+1.14%

HCA Price Performance
$477.57 (+4.04%)
$473.2 (+5.00%)
$413.53 (+20.15%)
$320.56 (+54.99%)
HCA Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Eps growth

Reported a weak earnings
Rating
Rating

Downgraded on weak valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
HCA Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
HCA Street Sentiment is extremely bullish and have positive views on the near-term outlook
HCA has Low risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 19, 2025
Reiterate
Outperform
Mizuho
Oct 18, 2025
Reiterate
Outperform
Mizuho
Oct 15, 2025
Reiterate
Buy
UBS
Oct 03, 2025
Reiterate
Buy
Cantor Fitzgerald
HCA Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program

Outperform the market
Risk Analysis

Downgraded on weak valued
HCA Latest Analysis
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Mon Feb 2, 2026
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Mon Feb 2, 2026
Heres Why HCA Healthcare (HCA) is a Strong Growth Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Fri Jan 30, 2026
Hospital Operator HCA Healthcare Is Set For Solid Growth Higher Value-Analyst. HCA) released mixed fourth-quarter 2025 financial results on Tuesday.HCA reported total revenues of $19.513 billion representing a 6.7% year-over-year increase missing the consensus estimate of $19.67 billion.The hospital chain operator reported adjusted earnings of $8.01 up from $6.22 a year ago surpassing the.HCA Healthcare forecasts fiscal 2026 earnings of $29.10-$31.50 per share compared to the consensus of $29.54
Wed Jan 28, 2026
HCA Healthcare Inc. (NYSE:HCA) Q4 2025 Earnings Call Transcript. HCA Healthcare Inc. (NYSE:HCA) Q4 2025 Earnings Call Transcript January 27 2026 HCA Healthcare Inc. beats earnings expectations. Reported EPS is $8.01 expectations were $7.46. Operator: Ladies and gentlemen welcome to HCA Healthcare Fourth Quarter 2025 Earnings Conference Call. Today’.s call is being recorded. At this time for opening remarks and introductions I would like [….]
Wed Jan 28, 2026
HCA Crosses Above Average Analyst Target. In recent trading shares of HCA Healthcare Inc (Symbol: HCA) have crossed above the average analyst 12-month target price of $497.77 changing hands for $505.84/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on
Wed Jan 28, 2026
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes. HCAs Q4 EPS surge 28.8% year over year to $8.01 beating estimates on strong patient volumes and higher revenue per equivalent admission.
Tue Jan 27, 2026
HCA Healthcare (HCA) Beats Q4 Earnings Estimates. HCA (HCA) delivered earnings and revenue surprises of 8.90% and -0.63% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Tue Jan 27, 2026
HCA Healthcare Tries To Break Out As Earnings Outlook Buyback Overcome This Blemish. HCA Healthcare earnings easily beat Q4 views with strong EPS guidance and big buyback offsetting a sales miss. HCA stock briefly broke out.The post HCA Healthcare Tries To Break Out As Earnings Outlook Buyback Overcome This Blemish appeared first on Investor'.s Business Daily.
Tue Jan 27, 2026
$100 Billion Market Cap Hospital Operator HCA Healthcare To Buy Back Stock Worth $10 Billion. HCA) one of the nation’.s largest hospital operators released mixed fourth-quarter 2025 financial results on Tuesday.HCA reported total revenues of $19.513 billion representing a 6.7% year-over-year increase missing the consensus estimate of $19.67 billion.The hospital chain operator reported adjusted earnings of $8.01 up from $6.22 a year ago surpassing the.Net income for the quarter reached $1.87
Tue Jan 27, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.